Global Cox-2 Inhibitors Market Growth (Status and Outlook) 2025-2031

September 2025 | 89 pages | ID: G190565990FEN
LP Information

Abstracts

According to this study, the global Cox-2 Inhibitors market size will reach US$ million by 2031.

Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.

In terms of regions, North America is expected to remain the largest market during the forecast period.

LPI (LP Information)' newest research report, the “Cox-2 Inhibitors Industry Forecast” looks at past sales and reviews total world Cox-2 Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected Cox-2 Inhibitors sales for 2025 through 2031. With Cox-2 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cox-2 Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global Cox-2 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cox-2 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cox-2 Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cox-2 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cox-2 Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of Cox-2 Inhibitors market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Selective Cox-2 Inhibitors
• Non Selective Cox-2 Inhibitors

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer
• Novartis
• Pfizer
• Merck
• Cadila Pharmaceuticals
• Sabinsa Corporation

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cox-2 Inhibitors Market Size (2020-2031)
  2.1.2 Cox-2 Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cox-2 Inhibitors by Country/Region (2020, 2024 & 2031)
2.2 Cox-2 Inhibitors Segment by Type
  2.2.1 Selective Cox-2 Inhibitors
  2.2.2 Non Selective Cox-2 Inhibitors
2.3 Cox-2 Inhibitors Market Size by Type
  2.3.1 Cox-2 Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cox-2 Inhibitors Market Size Market Share by Type (2020-2025)
2.4 Cox-2 Inhibitors Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Cox-2 Inhibitors Market Size by Application
  2.5.1 Cox-2 Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cox-2 Inhibitors Market Size Market Share by Application (2020-2025)

3 COX-2 INHIBITORS MARKET SIZE BY PLAYER

3.1 Cox-2 Inhibitors Market Size Market Share by Player
  3.1.1 Global Cox-2 Inhibitors Revenue by Player (2020-2025)
  3.1.2 Global Cox-2 Inhibitors Revenue Market Share by Player (2020-2025)
3.2 Global Cox-2 Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COX-2 INHIBITORS BY REGION

4.1 Cox-2 Inhibitors Market Size by Region (2020-2025)
4.2 Global Cox-2 Inhibitors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cox-2 Inhibitors Market Size Growth (2020-2025)
4.4 APAC Cox-2 Inhibitors Market Size Growth (2020-2025)
4.5 Europe Cox-2 Inhibitors Market Size Growth (2020-2025)
4.6 Middle East & Africa Cox-2 Inhibitors Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cox-2 Inhibitors Market Size by Country (2020-2025)
5.2 Americas Cox-2 Inhibitors Market Size by Type (2020-2025)
5.3 Americas Cox-2 Inhibitors Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cox-2 Inhibitors Market Size by Region (2020-2025)
6.2 APAC Cox-2 Inhibitors Market Size by Type (2020-2025)
6.3 APAC Cox-2 Inhibitors Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cox-2 Inhibitors Market Size by Country (2020-2025)
7.2 Europe Cox-2 Inhibitors Market Size by Type (2020-2025)
7.3 Europe Cox-2 Inhibitors Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cox-2 Inhibitors by Region (2020-2025)
8.2 Middle East & Africa Cox-2 Inhibitors Market Size by Type (2020-2025)
8.3 Middle East & Africa Cox-2 Inhibitors Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COX-2 INHIBITORS MARKET FORECAST

10.1 Global Cox-2 Inhibitors Forecast by Region (2026-2031)
  10.1.1 Global Cox-2 Inhibitors Forecast by Region (2026-2031)
  10.1.2 Americas Cox-2 Inhibitors Forecast
  10.1.3 APAC Cox-2 Inhibitors Forecast
  10.1.4 Europe Cox-2 Inhibitors Forecast
  10.1.5 Middle East & Africa Cox-2 Inhibitors Forecast
10.2 Americas Cox-2 Inhibitors Forecast by Country (2026-2031)
  10.2.1 United States Market Cox-2 Inhibitors Forecast
  10.2.2 Canada Market Cox-2 Inhibitors Forecast
  10.2.3 Mexico Market Cox-2 Inhibitors Forecast
  10.2.4 Brazil Market Cox-2 Inhibitors Forecast
10.3 APAC Cox-2 Inhibitors Forecast by Region (2026-2031)
  10.3.1 China Cox-2 Inhibitors Market Forecast
  10.3.2 Japan Market Cox-2 Inhibitors Forecast
  10.3.3 Korea Market Cox-2 Inhibitors Forecast
  10.3.4 Southeast Asia Market Cox-2 Inhibitors Forecast
  10.3.5 India Market Cox-2 Inhibitors Forecast
  10.3.6 Australia Market Cox-2 Inhibitors Forecast
10.4 Europe Cox-2 Inhibitors Forecast by Country (2026-2031)
  10.4.1 Germany Market Cox-2 Inhibitors Forecast
  10.4.2 France Market Cox-2 Inhibitors Forecast
  10.4.3 UK Market Cox-2 Inhibitors Forecast
  10.4.4 Italy Market Cox-2 Inhibitors Forecast
  10.4.5 Russia Market Cox-2 Inhibitors Forecast
10.5 Middle East & Africa Cox-2 Inhibitors Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cox-2 Inhibitors Forecast
  10.5.2 South Africa Market Cox-2 Inhibitors Forecast
  10.5.3 Israel Market Cox-2 Inhibitors Forecast
  10.5.4 Turkey Market Cox-2 Inhibitors Forecast
10.6 Global Cox-2 Inhibitors Forecast by Type (2026-2031)
10.7 Global Cox-2 Inhibitors Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cox-2 Inhibitors Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer Cox-2 Inhibitors Product Offered
  11.1.3 Bayer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bayer Main Business Overview
  11.1.5 Bayer Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Cox-2 Inhibitors Product Offered
  11.2.3 Novartis Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Cox-2 Inhibitors Product Offered
  11.3.3 Pfizer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Merck
  11.4.1 Merck Company Information
  11.4.2 Merck Cox-2 Inhibitors Product Offered
  11.4.3 Merck Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Merck Main Business Overview
  11.4.5 Merck Latest Developments
11.5 Cadila Pharmaceuticals
  11.5.1 Cadila Pharmaceuticals Company Information
  11.5.2 Cadila Pharmaceuticals Cox-2 Inhibitors Product Offered
  11.5.3 Cadila Pharmaceuticals Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Cadila Pharmaceuticals Main Business Overview
  11.5.5 Cadila Pharmaceuticals Latest Developments
11.6 Sabinsa Corporation
  11.6.1 Sabinsa Corporation Company Information
  11.6.2 Sabinsa Corporation Cox-2 Inhibitors Product Offered
  11.6.3 Sabinsa Corporation Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Sabinsa Corporation Main Business Overview
  11.6.5 Sabinsa Corporation Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cox-2 Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cox-2 Inhibitors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Selective Cox-2 Inhibitors
Table 4. Major Players of Non Selective Cox-2 Inhibitors
Table 5. Cox-2 Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Cox-2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Cox-2 Inhibitors Market Size Market Share by Type (2020-2025)
Table 8. Cox-2 Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Cox-2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Cox-2 Inhibitors Market Size Market Share by Application (2020-2025)
Table 11. Global Cox-2 Inhibitors Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Cox-2 Inhibitors Revenue Market Share by Player (2020-2025)
Table 13. Cox-2 Inhibitors Key Players Head office and Products Offered
Table 14. Cox-2 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cox-2 Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Cox-2 Inhibitors Market Size Market Share by Region (2020-2025)
Table 19. Global Cox-2 Inhibitors Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Cox-2 Inhibitors Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Cox-2 Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Cox-2 Inhibitors Market Size Market Share by Country (2020-2025)
Table 23. Americas Cox-2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Cox-2 Inhibitors Market Size Market Share by Type (2020-2025)
Table 25. Americas Cox-2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Cox-2 Inhibitors Market Size Market Share by Application (2020-2025)
Table 27. APAC Cox-2 Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Cox-2 Inhibitors Market Size Market Share by Region (2020-2025)
Table 29. APAC Cox-2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Cox-2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Cox-2 Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Cox-2 Inhibitors Market Size Market Share by Country (2020-2025)
Table 33. Europe Cox-2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Cox-2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Cox-2 Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cox-2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cox-2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cox-2 Inhibitors
Table 39. Key Market Challenges & Risks of Cox-2 Inhibitors
Table 40. Key Industry Trends of Cox-2 Inhibitors
Table 41. Global Cox-2 Inhibitors Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Cox-2 Inhibitors Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Cox-2 Inhibitors Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Cox-2 Inhibitors Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Bayer Details, Company Type, Cox-2 Inhibitors Area Served and Its Competitors
Table 46. Bayer Cox-2 Inhibitors Product Offered
Table 47. Bayer Cox-2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Bayer Main Business
Table 49. Bayer Latest Developments
Table 50. Novartis Details, Company Type, Cox-2 Inhibitors Area Served and Its Competitors
Table 51. Novartis Cox-2 Inhibitors Product Offered
Table 52. Novartis Cox-2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Pfizer Details, Company Type, Cox-2 Inhibitors Area Served and Its Competitors
Table 56. Pfizer Cox-2 Inhibitors Product Offered
Table 57. Pfizer Cox-2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Merck Details, Company Type, Cox-2 Inhibitors Area Served and Its Competitors
Table 61. Merck Cox-2 Inhibitors Product Offered
Table 62. Merck Cox-2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Merck Main Business
Table 64. Merck Latest Developments
Table 65. Cadila Pharmaceuticals Details, Company Type, Cox-2 Inhibitors Area Served and Its Competitors
Table 66. Cadila Pharmaceuticals Cox-2 Inhibitors Product Offered
Table 67. Cadila Pharmaceuticals Cox-2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Cadila Pharmaceuticals Main Business
Table 69. Cadila Pharmaceuticals Latest Developments
Table 70. Sabinsa Corporation Details, Company Type, Cox-2 Inhibitors Area Served and Its Competitors
Table 71. Sabinsa Corporation Cox-2 Inhibitors Product Offered
Table 72. Sabinsa Corporation Cox-2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Sabinsa Corporation Main Business
Table 74. Sabinsa Corporation Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cox-2 Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cox-2 Inhibitors Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cox-2 Inhibitors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cox-2 Inhibitors Sales Market Share by Country/Region (2024)
Figure 8. Cox-2 Inhibitors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cox-2 Inhibitors Market Size Market Share by Type in 2024
Figure 10. Cox-2 Inhibitors in Hospital Pharmacies
Figure 11. Global Cox-2 Inhibitors Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Cox-2 Inhibitors in Retail Pharmacies
Figure 13. Global Cox-2 Inhibitors Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Cox-2 Inhibitors in Online Pharmacies
Figure 15. Global Cox-2 Inhibitors Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Cox-2 Inhibitors Market Size Market Share by Application in 2024
Figure 17. Global Cox-2 Inhibitors Revenue Market Share by Player in 2024
Figure 18. Global Cox-2 Inhibitors Market Size Market Share by Region (2020-2025)
Figure 19. Americas Cox-2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 20. APAC Cox-2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 21. Europe Cox-2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Cox-2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 23. Americas Cox-2 Inhibitors Value Market Share by Country in 2024
Figure 24. United States Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Cox-2 Inhibitors Market Size Market Share by Region in 2024
Figure 29. APAC Cox-2 Inhibitors Market Size Market Share by Type (2020-2025)
Figure 30. APAC Cox-2 Inhibitors Market Size Market Share by Application (2020-2025)
Figure 31. China Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 35. India Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Cox-2 Inhibitors Market Size Market Share by Country in 2024
Figure 38. Europe Cox-2 Inhibitors Market Size Market Share by Type (2020-2025)
Figure 39. Europe Cox-2 Inhibitors Market Size Market Share by Application (2020-2025)
Figure 40. Germany Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 41. France Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Cox-2 Inhibitors Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Cox-2 Inhibitors Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Cox-2 Inhibitors Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Cox-2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 54. APAC Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 55. Europe Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 57. United States Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 58. Canada Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 59. Mexico Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 60. Brazil Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 61. China Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 62. Japan Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 63. Korea Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 65. India Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 66. Australia Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 67. Germany Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 68. France Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 69. UK Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 70. Italy Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 71. Russia Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 72. Egypt Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 73. South Africa Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 74. Israel Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 75. Turkey Cox-2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 76. Global Cox-2 Inhibitors Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Cox-2 Inhibitors Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Cox-2 Inhibitors Market Size 2026-2031 ($ millions)